Division of Innovative Research and Development Advanced Research & Development Programs for Medical Innovation(AMED-CREST)
Etiological Basics of and Techniques for Treatment of Allergic and Autoimmune Diseases (Completed)
[Strategic Objective] Development of medical technology using immunoregulation to overcome allergic and autoimmune diseases including pollinosis
Outline of the Research & Development (R&D) Area
This R&D area aims to improve prevention, diagnosis, and treatment of human immunological diseases, centered on allergic and autoimmune diseases, and includes research for development of basic technologies for improvement of appropriate functioning of the immune system.
Diseases centered on allergic responses and autoimmune systems vary from those that may lower the quality of life (QOL) of patients to those leading to death in serious cases. Deepened understanding of the immune mechanism and control of such diseases at levels of molecules, cells, organs, and tissues will be evolved into understanding of a higher-level control immune network system at individual levels, leading to clinical application.
Specific examples of research projects include immunoregulatory mechanisms by regulatory cells, construction mechanisms of the mucous membrane immune system, autoimmune system, acquired immune system, and natural immune system and their control, etiological mechanisms of autoimmune and allergic diseases, immune and infection control mechanisms, development of drugs and vaccines against diseases and measurement of their effects, establishment of methods for diagnosis and treatment of diseases, and so forth.
Year the Area adopted
2010
Management and Evaluation Framework
Program Supervisor (PS)
- SUGAMURA Kazuo
- Chief Director, Miyagi Prefectural Hospital Organization
R&D Area Advisors
- SAITO Takashi
- Group Director, RIKEN Yokohama Institute
- SAKAGUCHI Shimon
- Professor, Osaka University
- SHIBUYA Kazuko
- Associate Professor, University of Tsukuba
- TAKATSU Kiyoshi
- Director, Toyama Prefectual institute for Pharmaceutical Research
- TOKUHISA Takeshi
- President, Chiba University
- NOSE Masato
- Professor Emeritus, Ehime University
- HANAI Nobuo
- President, Kyowa Hakko Kirin Co., LTD.
- MIYASAKA Nobuyuki
- Professor, Tokyo Medical and Dental University
- YAMAMOTO Kazuhiko
- Professor, The University of Tokyo
Brochure
Last updated 04/17/20